Mr. Anil Raghavan

CEO 

Mr. Anil Raghavan has been the Chief Executive Officer of Sun Pharma Advanced Research Company Limited since April 24, 2014. Mr. Raghavan is a senior pharmaceutical services executive with significant global exposure spanning business strategy and operations. He served as the Managing Director of the India and Sri Lanka business of Quintiles.

He was part of the Quintiles global leadership team and an active member of the management board. Under his watch, Quintiles India maintained strong double-digit revenue and operating surplus growth in a turbulent external business environment.

He provided key inputs to help the global leadership team rethink their corporate strategy to sustain the enterprise’s leadership and executed several strategic partnerships and M&A opportunities for the Sun Pharma Advanced Research Company. Prior to joining Quintiles, he spent a decade consulting with leading firms such as Arthur Andersen, KPMG and Cambridge Technology Partners.

He helped the leadership teams of several companies in developing and evaluating strategies, and improving business performance. He was instrumental in setting up KPMG’s media consulting group in India and contributed significantly to growing Arthur Andersen’s consulting business in the country.

An active speaker at events, he has participated in several industry sector studies, working with business lobbies and industry associations to highlight sectoral opportunities and challenges. He serves as a Member of Advisory Board of Medwell Ventures Private Limited.

Mr. Raghavan is a B.Tech. in Industrial Engineering from University of Kerala (College of Engineering, Trivandrum) with a deep interest in the evolving technologies of the pharmaceutical R&D and health care delivery segments.